MPDU1 anticorps (C-Term)

N° du produit ABIN1881550

Détail du produit anti-MPDU1 anticorps

Antigène: MPDU1 (Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Épitope: AA 219-247, C-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MPDU1 est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This MPDU1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 219-247 amino acids from the C-terminal region of human MPDU1.

Clone: RB42402

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-MPDU1 (ABIN1881550)

Guey, García-Closas, Murta-Nascimento, Lloreta, Palencia, Kogevinas, Rothman, Vellalta, Calle, Marenne, Tardón, Carrato, García-Closas, Serra, Silverman, Chanock, Real, Malats: "Genetic susceptibility to distinct bladder cancer subphenotypes." dans: European urology, Vol. 57, Issue 2, pp. 283-92, (2010) (PubMed).

Hosgood, Menashe, He, Chanock, Lan: "PTEN identified as important risk factor of chronic obstructive pulmonary disease." dans: Respiratory medicine, Vol. 103, Issue 12, pp. 1866-70, (2009) (PubMed).

Shen, Vermeulen, Rajaraman, Menashe, He, Chapman, Yeager, Thomas, Burdett, Hutchinson, Yuenger, Chanock, Lan: "Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China." dans: Environmental and molecular mutagenesis, Vol. 50, Issue 4, pp. 285-90, (2009) (PubMed).

Hosgood, Menashe, Shen, Yeager, Yuenger, Rajaraman, He, Chatterjee, Caporaso, Zhu, Chanock, Zheng, Lan: "Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway." dans: Carcinogenesis, Vol. 29, Issue 10, pp. 1938-43, (2008) (PubMed).

Détails sur MPDU1

Antigène: MPDU1 (Mannose-P-Dolichol Utilization Defect 1 (MPDU1))

Autre désignation: MPDU1 (MPDU1 Produits)

Synonymes: anticorps CDGIF, anticorps HBEBP2BPA, anticorps Lec35, anticorps My008, anticorps PP3958, anticorps PQLC5, anticorps SL15, anticorps LEC35, anticorps Supl15h, anticorps mpdu1, anticorps zgc:92112, anticorps MPDU1, anticorps DDBDRAFT_0237930, anticorps DDB_0237930, anticorps fb18d03, anticorps wu:fb18d03, anticorps zgc:86765, anticorps mannose-P-dolichol utilization defect 1, anticorps mannose-P-dolichol utilization defect 1a, anticorps cystinosin/ERS1p repeat-containing protein, anticorps mannose-P-dolichol utilization defect 1b, anticorps MPDU1, anticorps Mpdu1, anticorps mpdu1a, anticorps mpdu1, anticorps LOC692905, anticorps mpdu1b

Sujet: This gene encodes an endoplasmic reticulum membrane protein that is required for utilization of the mannose donor mannose-P-dolichol in the synthesis of lipid-linked oligosaccharides and glycosylphosphatidylinositols. Mutations in this gene result in congenital disorder of glycosylation type If. Alternative splicing results in multiple transcript variants.

Poids moléculaire: 26638

NCBI Accession: NP_004861

UniProt: O75352